Vicki Moore, PhD

Health-related quality of life in bladder cancer does not appear impaired with transurethral resection but may be worse with radical treatment.

Researchers developed a tool to predict risk of long-term cardiovascular disease-related death in patients with bladder cancer.

Researchers sought to determine whether the use of bendamustine use before CAR-T therapy would impact outcomes for patients with LBCL.

Researchers sought to determine the prognostic significance of several forms of hyperdiploidy in acute lymphoblastic leukemia

Researchers explored themes related to nutritional management in patients undergoing treatment for esophageal cancer.

Patient-physician agreement on function and pain at baseline and over time correlated with better outcomes for some patients with sarcoma.

A family history of bladder cancer was linked to increased risk of the disease, particularly for smokers but not statistically significant for alcohol users.

Multiple measures for patient outcomes were improved with a continuous care model compared with usual care in a study of patients receiving chemotherapy for advanced colorectal cancer.

Use of general or specialty palliative care was associated with reductions in pain among adolescents and young adults with cancer.

The combination of sotorasib and panitumumab outperformed investigator’s choice of therapy in a phase 3 trial of patients with chemorefractory, KRAS G12C-mutated metastatic colorectal cancer.